基于DNAzyme的超敏感检测平台,该平台基于阻断CRISPR/Cas12a系统的超敏感检测平台
Xuening Shi1, Jing Zhang1, Yukun Ding1
1State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, School of Public Health, Jilin University, Changchun, 130021, China.
Biosensors & bioelectronics
|August 20, 2024
概括
这项研究引入了一种快速的CRISPR/Cas12a和DNAzyme试验,用于检测黄金葡萄球菌 (S. aureus) 没有放大. 该方法在短短29分钟内实现了灵敏的检测,改善了食品安全和公共卫生诊断.
科学领域:
- 生物技术是生物技术.
- 分子诊断学 分子诊断
- 食品安全 食品安全
背景情况:
- 克里斯普尔/Cas12a系统对于检测病原体至关重要,但往往需要放大,增加时间和污染风险.
- 目前用于敏感病原体检测的方法面临着速度和复杂性的挑战.
研究的目的:
- 使用CRISPR/Cas12a和DNAzyme.开发一种快速,灵敏和无放大检测金黄色葡萄球菌 (金黄色葡萄球菌) 的策略.
- 克服现有的基于CRISPR的检测方法的局限性,例如延长检测时间和核酸污染.
主要方法:
- 采用一种修改后的CRISPR/Cas12a系统,该系统具有受阻的Cas12a活性 (bcrRNA),该系统由从蚀刻的MnO2纳米颗粒中释放的Mn2+重新激活.
- 特定于S. aureus的功能化磁性 (Fe3O4) 和MnO2纳米颗粒捕获了目标细菌.
- 由Mn2+触发的DNA酶活性,分裂了bcrRNA,恢复了CRISPR/Cas12a功能以进行检测.
主要成果:
- 该试验实现了超敏感的黄金色细菌定量检测,检测极限 (LOD) 为5CFU/mL.
- 整个检测过程在29分钟内迅速完成.
- 该方法在不需要核酸提取或放大的情况下表现出高性能.
结论:
- 开发的CRISPR/Cas12a和DNAzyme战略为S. aureus检测提供了一个快速而敏感的平台.
- 这种无放大方法通过减少时间和污染风险来提高食品安全和公共卫生诊断.
- 该平台的适应性表明,有可能为各种目标制定通用检测策略.
相关概念视频
CRISPR and crRNAs
16.9K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
16.9K
CRISPR
50.0K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
50.0K


